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Abstract
Background: Data on the prevalence of valvular heart disease in very old individuals are scarce and based mostly
on in-hospital series. In addition, the potential detrimental effect of valvular heart disease on the activities of daily
living is unknown. The present study evaluated the prevalence of significant valvular heart disease and the impact
of valvular heart disease on the activities of daily living in community dwelling nonagenarians. Nested within the
Leiden 85-plus study, a population based follow-up study of the oldest old, a sample of 81 nonagenarians was
recruited.
Methods: The left ventricular (LV) dimensions, function and the presence and severity of heart valvular disease
were evaluated by echocardiography. Significant valvular heart disease included any mitral or aortic stenosis
severity, moderate or severe mitral regurgitation, moderate or severe aortic regurgitation and moderate or severe
tricuspid regurgitation. Activities of daily living were assessed using the Groningen Activity Restriction Scale (GARS).
Results: LV cavity diameters (end-diastolic diameter 47 ± 8 mm, end-systolic diameter 30 ± 8 mm) and systolic LV
function (LV ejection fraction 66 ± 13%) were within normal for the majority of the participants. Significant valvular
disease was present in 57 (70%) individuals, with mitral regurgitation and aortic regurgitation as the most frequent
valve diseases (49% and 28% respectively). The GARS score between individuals with and without significant
valvular heart disease was similar (36.2 ± 9.2 vs. 34.4 ± 13.2, p = 0.5).
Conclusions: Nonagenarian, outpatient individuals have a high prevalence of significant valvular heart disease.
However, no relation was observed between the presence of significant valvular heart disease and the ability to
perform activities of daily living.
Background
The increasing life expectancy of the population in the
Western countries has determined an increase of
chronic diseases, with cardiovascular disease being one
of the most prevalent pathologies[1]. The elderly indivi-
duals comprise a growing demographic subgroup char-
acterized by a high frequency of cardiovascular risk
factors and co-morbidities[2]. Furthermore, this sub-
group of individuals is often excluded from randomized
trials, resulting in important implications for clinical
management[3,4]. Particularly, data on the prevalence of
valvular heart disease in very old individuals are scarce
and based mostly on in-hospital series, introducing an
important selection bias [4-7]. In addition, the potential
detrimental effect of valvular heart disease on the activ-
ities of daily living is unknown.
T h ea i mo ft h ep r e s e n ts t u d yw a st w o f o l d .F i r s t ,t h e
prevalence of significant valvular heart disease was
e v a l u a t e di nag r o u po fo u t p a t i e n ti n d i v i d u a l sa g e d
90 years. Second, the impact of significant valvular
heart disease on the performance in different activities
of daily living was studied. Valvular heart disease was
defined according to the Euro Heart Survey on Valvu-
lar Heart Disease[4].
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Study protocol
The Leiden 85-plus Study is a prospective population-
based study of all 85-year old inhabitants of Leiden, The
Netherlands. The study design and characteristics of the
cohort were described in detail previously[8,9]. In short,
between September 1997 and September 1999 all 705
members of the 1912 to 1914-birth cohort in the city of
Leiden were asked to participate in the month after
their 85
th birthday. There were no selection criteria
related to health or demographic characteristics. Partici-
pants were followed until death or the age of 90 years.
At baseline and yearly thereafter, 85-year old partici-
pants were visited at their place of residence. During
these visits blood pressure was measured, a venous
blood sample drawn, an electrocardiogram recorded and
face-to-face interviews and performance tests conducted.
At 90 years of age, the participants were invited for an
echocardiographic examination. Participants gave
informed consent and for individuals who were severely
cognitively impaired, a guardian gave informed consent.
The Medical Ethics Commission of Leiden University
approved the study.
Clinical evaluation
Clinical status was evaluated in all individuals using the
Groningen Activity Restriction Scale (GARS), a one-
dimensional questionnaire that assess the performance
in basic and instrumental activities of daily living (ADL
and IADL)[10]. The score ranges from 18 to 90, higher
scores indicating increasing disability. Cognitive function
was assessed by the Mini-Mental State Examination
(MMSE), with scores ranging from 0 to 30 points (opti-
mal)[10]. Depressive symptoms were measured in those
with MMSE > 18 points, using the 15-item Geriatric
Depression Scale (GDS-15), with scores ranging from 0
to 15 points (optimal)[10]. A GDS-15 score above 4 was
considered to be poor. The cardiovascular history was
recorded, including history of coronary artery disease
(medical history of angina or myocardial infarction),
bypass surgery, stroke, and peripheral vascular disease
[9]. Heart failure was defined as a positive response of
the general practitioner to a specific question.
Blood pressure was measured twice with an interval of
two weeks, using a mercury sphygmomanometer, in
seating position after at least five minutes rest without
having performed vigorous exercise during the preced-
ing 30 minutes. We used the mean of the assessed sys-
tolic values and diastolic values.
Echocardiography
Transthoracic 2-dimensional echocardiography was per-
formed in all individuals in the left lateral decubitus
position. Images were obtained using a commercially
available system equipped with a 3.5-MHz transducer
(Vingmed system Vivid-5; General Electric-Vingmed,
Milwaukee, WI, USA). Standard gray-scale and color
Doppler images were acquired at a depth of 16 cm at
the parasternal (standard long- and short-axis images)
and apical views (2-, 4-chamber and apical long-axis
images). Data were stored for further off-line analysis.
Left ventricular (LV) diameters, interventricular septal
(end-diastolic) thickness and posterior wall (end-diasto-
lic) thickness were measured from M-mode images
obtained from the parasternal long-axis view, and LV
ejection fraction was derived using the Teichholz for-
mula[11]. Left ventricular mass was calculated by the
cube formula, using the correction formula proposed by
Devereux et al[12]. Left ventricular mass was indexed by
the body surface area. According to previous criteria, LV
hypertrophy was defined by a LV mass index > 110 g/
m
2 in women and >134 g/m
2 in men[13]. Finally, left
atrial dimension was calculated by measuring the ante-
roposterior diameter from M-mode recordings of the
parasternal long-axis view.
Left ventricular diastolic function was evaluated by
measuring the transmitral peak velocities (E-wave and
A-wave) obtained from pulsed-wave Doppler recordings
of the transmitral inflow velocity; from these velocities
the E/A ratio derived as another marker of LV diastolic
function[13].
The valvular assessment included the evaluation of the
function of the mitral, aortic and tricuspid valves.
Color-Doppler echocardiography was performed after
optimizing gain and Nyquist limit, and standard contin-
uous and pulsed-wave Doppler recordings were
acquired. Stenotic and regurgitant valve diseases were
evaluated according to semiquantitative and quantitative
methods recommended by the American Society of
Echocardiography[13,14]. The severity of valvular steno-
sis was based on the valve area and the mean pressure
gradient across the restrictive orifice[15]. The mitral
valve area was calculated by the pressure half-time and
the aortic valve area was calculated by the continuity
equation[13,16]. The mean pressure gradient across the
restrictive orifice was estimated by averaging the instan-
taneous gradients obtained from continuous wave Dop-
pler recordings[13]. In addition, the severity of valvular
regurgitation was determined on a qualitative scale and
classified as mild (grade 1), moderate (grade 2) and
severe (grades 3-4), according to the current ACC/AHA
guidelines for the management of individuals with valvu-
lar heart disease[15]. According to the Euro Heart Sur-
vey on Valvular Heart Disease, significant valvular
disease was defined as any mitral or aortic stenosis
severity, moderate or severe mitral regurgitation, moder-
ate or severe aortic regurgitation[4]. In addition, moder-
ate or severe tricuspid regurgitation was considered as
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regurgitation was present, the pulmonary artery pressure
was estimated using the modified Bernoulli equation.
Statistical analysis
Continuous variables are presented as mean ± SD and
categorical variables are presented as numbers and per-
centages. Differences between individuals with signifi-
cant valvular disease and individuals without valvular
disease were compared by the 2-tailed Student t-test,
ANOVA, Mann-Whitney test and c
2-test for unpaired
data, when appropriate. All statistical analyses were per-
formed with software SPSS for Windows version 12.0
(SPSS, Inc., Chicago, IL). A p value <0.05 was consid-
ered statistically significant.
Results
Of the initial 705 eligible participants at the Leiden
85-plus study, 14 died before they could be enrolled and
92 refused to participate, resulting in a cohort of 599
participants who could be enrolled at age 85 (87%
response). Some 277 participants survived up to age
90 years and were in principle eligible for the study.
Among them, 81 outpatient individuals underwent echo-
cardiography. The remaining 196 individuals were not
able to visit the study center. Clinical and demographic
characteristics are presented in Table 1. All individuals
with echocardiographic examination were 90 years old
(33% men). The majority of the individuals were in
sinus rhythm (93%). The mean body surface area was
1,7 m
2 [SD ± 0.7].
Echocardiography
The echocardiographic characteristics of the study
population are summarized in Table 2. The majority of
the individuals showed normal LV dimensions and pre-
served systolic LV function. Seven (9%) individuals had
LV systolic dysfunction (LV ejection fraction <50%).
According to the previous definition, LV hypertrophy
was present in 40 (51%) individuals, without differences
between men and women (12 (44%) vs. 28 (55%),
respectively; p = 0.5). Mean anteroposterior diameter of
the left atrium was 42 ± 9 mm. An enlarged left atrium
(anteroposterior diameter > 40 mm) was present in 43
(53%) individuals. Evaluation of LV diastolic function
demonstrated impaired LV relaxation in the majority of
the individuals, reflected by an E/A ratio <1.
Data on heart valve study are presented in Table 3.
Significant valvular disease was observed in 57 (70%)
individuals. Significant left-sided valvular disease invol-
ving only one valve (mitral or aortic) was noted in 38
(47%) individuals, whereas 23 (28%) individuals had
both the mitral and the aortic valves involved.
Mitral and aortic regurgitation were the most com-
mon valvular diseases diagnosed and no patient had
mitral stenosis. Significant mitral regurgitation was
observed in 39 (49%) individuals: 24 (30%) individuals
had moderate mitral regurgitation and 15 (19%) indivi-
duals had severe mitral regurgitation. Significant aortic
regurgitation was observed in 23 (28%) individuals: 17
(21%) individuals had moderate aortic regurgitation and
6 (7%) individuals had severe aortic regurgitation. Aortic
stenosis was present in 14 (17%) individuals: 9 (11%)
individuals had mild aortic stenosis, 4 (5%) individuals
had moderate aortic stenosis and only 1 (1%) patient
had severe aortic stenosis. Finally, moderate to severe
tricuspid regurgitation was observed in 17 (21%) indivi-
duals, together with significant left-sided valvular heart
disease. The mean (SD) pulmonary artery pressure in
these individuals was 35 (± 7) mmHg. Figure 1 shows
Table 1 Clinical and demographic characteristics
Echocardiograpic examination
Yes [n = 81] No [n = 196] p value
Females [%] 67 75 0.20*
Living independently [%] 78 55 <0.001*
ADL (IQR) [points] 10 (9-14) 16 (10-25) <0.001‡
IADL (IQR) [points] 23 (17-29) 33 (25-36) <0.001‡
GARS (IQR) [points] 33 (26-42) 49 (35-61) <0.001‡
MMSE (IQR) [points] 28 (26-29) 22 (15-27) <0.001‡
GDS-15 (>4) [%] 14.8 32 <0.001‡
History of cardiovascular
disease [%]†
35 43 0.15*
History of heart failure
[%]
19 17 0.82*
Diastolic blood pressure
(SD) [mmHg]
73 (9) 71 (10) 0.17*
Systolic blood pressure
(SD) [mmHg]
155 (16) 150 (19) 0.03*
SD, Standard Deviation. IQR, Inter Quartile Range. ADL, Activities in Daily
Living. IADL, Instrumental Activities in Daily Living. GARS, Groningen Activity
Restriction Scale. MMSE, Mini Mental State Examination. GDS-15, Geriatric
Depression Scale. †, Including cerebrovascular accident, angina pectoris,
myocardial infarction, peripheral vascular disease or an electrocardiogram
revealing myocardial ischemia or infarction. *, Independent T-test. ‡, Mann
Whitney test. N, number of participants.
Table 2 Left ventricular dimensions and function
Mean [SD]
LV end-diastolic diameter (mm) 47 ± 8
LV end-systolic diameter (mm) 30 ± 8
Interventricular septum thickness (mm) 13 ± 3
Posterior wall thickness (mm) 11 ± 2
LV ejection fraction (%) 66 ± 13
LV mass index (g/m
2) 126 ± 37
Left atrium diameter (mm) 42 ± 9
E/A ratio 0.7 ± 0.2
81 participants included. LV = left ventricular. SD = Standard Deviation.
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disease. Concomitant significant mitral valve disease and
significant aortic or tricuspid valve disease were the
most common combinations of valve disease.
Ability to perform activities of daily living and
heart valvular disease
Differences in functional status as assessed by the GARS
score were evaluated between individuals with and with-
out significant valve disease. Patients with and without
moderate or severe valvular heart disease showed com-
parable GARS score: 34.8 ± 13.4 vs. 34.8 ± 9.4, p = 0.97.
Furthermore, there were no differences in the GARS
score between individuals without, one or two valves
being significantly diseased (p = 0.6) (Table 4).
Discussion
The findings in the current study illustrate that the
majority of the nonagenarian outpatient individuals have
normal LV cavity dimensions and normal systolic LV
function on echocardiography. However, the prevalence
of significant valvular disease is high, with mitral and
aortic valve regurgitation being the most frequent valvu-
lar diseases. Nonetheless, the presence of significant
Table 3 Valvular heart disease in the study population
Mitral Valve
Mitral stenosis (%) 0 (0%)
Mitral regurgitation (%) 59 (73%)
Mild 20 (25%)
Moderate 24 (30%)
Severe 15 (19%)
Aortic Valve
Aortic stenosis (%) 14 (17%)
Mild (mean ΔP < 25 mmHg) 9 (11%)
Moderate (mean ΔP 25 - 40 mmHg) 4 (5%)
Severe (mean ΔP > 40 mmHg) 1 (1%)
Aortic regurgitation (%) 38 (47%)
Mild 15 (19%)
Moderate 17 (21%)
Severe 6 (7%)
Tricuspid valve
Tricuspid stenosis (%) 0 (0%)
Tricuspid regurgitation (%) 25 (31%)
Mild 8 (10%)
Moderate 5 (6%)
Severe 12 (15%)
81 participants included. ΔP = pressure gradient.
Figure 1 Prevalence of combined significant valvular heart disease.
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functional status that was assessed with the GARS score.
Echocardiographic characteristics of the nonagenarian
population
The nonagenarian outpatient population evaluated in the
present study showed normal LV cavity dimensions and
preserved systolic LV function. In contrast, diastolic LV
function was characterized mostly by impaired LV relaxa-
tion. Several previous studies have reported similar find-
ings in elderly individuals, with normal values of LV
diameters and preserved systolic LV function, but with dif-
ferent grades of diastolic dysfunction[6,17]. As previously
described, the aged-related changes in cardiac structure
comprise a progressive increase in LV wall thickness
whereas LV diameters and systolic LV function remain
unchanged[18]. In addition, the increasing LV stiffness
and collagen deposition that accompany the patient’s
aging, result in delayed LV relaxation and impairment of
the early LV diastolic filling[18]. All these changes were
observed in the present study, with an increased LV mass
index (126 ± 37 g/m
2) together with normal LV cavity dia-
meters. Furthermore, various indices of diastolic dysfunc-
tion were abnormal (e.g. an E/A ratio <1 or an enlarged
left atrium) indicating impaired LV compliance.
However, all these structural and functional changes
are strongly influenced by the presence of cardiovascular
disease (i.e. coronary artery disease, valvulopathies or
hypertension), the most common co-morbidity among
the elderly individuals.
Importantly, a high prevalence of valvular heart disease
was observed in the present study population, with mitral
and aortic valve regurgitation as the most frequent valvu-
lopathies. Several contemporary series from Europe and
the United States have demonstrated the relation between
aging and the prevalence of degenerative valvular heart
disease[4,6,7,19]. However, the true burden of valve dis-
ease remains still unclear since the majority of those ser-
ies included in-hospital individuals or individuals referred
for valvular surgery, introducing an important selection
bias[4,6,7]. Recently, Nkomo et al. demonstrated, in a
community study including 3851 individuals older than
75 years, high absolute rates of significant valvular heart
disease (11.7%), with mitral regurgitation and aortic ste-
nosis being the most frequent valve diseases (7.1% and
4.6%, respectively)[7]. Furthermore, Sadiq et al. evaluated
the distribution pattern of moderate to severe valve dis-
ease among 63 hospitalised centenarian individuals, a sig-
nificant minority of them were admitted because of
cardiovascular events (35%)[6]. In that study, aortic steno-
s i sw a st h em o s tp r e v a l e n tv a l v ed i s e a s e( 2 7 % )f o l l o w e d
by mitral regurgitation (22%) and aortic regurgitation
(17%)[6]. Whereas in the aforementioned series the popu-
lation comprised individuals with known valve disease or
in-hospital individuals,[6,7] the present population con-
sisted of clinically stable and mostly independently living
nonagenarians from the general population. The high
prevalence of valvular heart disease as observed in the
present study when compared to previous studies is diffi-
cult to explain because of the different clinical character-
istics. As previously described, aortic stenosis is
characterized by poor clinical tolerance and, therefore,
may determine higher hospital admission rates and
higher prevalence of this particular valve disease in the
inpatient-based series.
Impact of valvular disease on the ability in activities
of daily living
In the current study, the competence in basic and
instrumental activities of daily living was evaluated using
the GARS score and related to the presence of valvular
heart disease. Importantly, no differences in GARS score
were observed between individuals with and without sig-
nificant valve disease.
The relation between the impairments of basic activities
of daily living and instrumental activities of daily living
and cardiovascular co-morbidities has not been exten-
sively studied[20,21]. Maugeri et al. related several para-
meters (e.g. walking speed, cognitive function, personal
care) to systolic LV function in 170 individuals older
than 70 years[21]. The authors demonstrated significant
functional disability in those individuals with heart failure,
whereas individuals with preserved systolic LV function
obtained better scores in the tests[21]. In contrast, For-
miga et al. evaluated the predictors of functional decline
in 97 nonagenarians at 1 year follow-up and identified a
history of stroke as an independent risk factor whereas
the history of ischemic cardiomyopathy or heart failure
were not related to functional decline[20].
The current study demonstrated that no relation
existed between the performance in activities of daily
living and the presence of significant valvular heart
Table 4 Relation between GARS score and significant valvular disease
No valvular disease
(N = 20)
Any valvular disease
(N = 61)
One valve diseased
(N = 38)
Two valve diseased
(N = 23)
GARS score
Mean (SD) 36.2 ± 9.2 34.4 ± 13.2 * 35.4 ± 14.4 32.7 ± 11.1
†‡
N = number of participants. * p = 0.5 vs. No valvular heart disease. † p = 0.4 one valve diseased vs. two valves diseased.
‡ ANOVA p-value = 0.6 No valvular
disease vs. one and two valves diseased. SD = Standard Deviation.
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observed in the majority of the population could pre-
clude us to find differences in functional status between
individuals with and without significant valve disease.
Additional large studies, including individuals with a
broad range of systolic LV function, may provide more
insight into the relation between the competence in
activities of daily living and the presence of valvular
heart disease.
Study Limitations
Although this was a population-based study, the
included participants had an overall significant better
physical and cognitive performance than those partici-
pants who were not included in this study. Therefore
this study population represents a selected group of out-
patient nonagenarians and hence, the results may not
apply to the general population of nonagenarians.
Although, the GARS score is a validated score reflect-
ing the limitations in daily life other more physical tests
might have been more appropriate to use. However, the
GARS score gives a valuable insight in the limitations of
daily life that was related to valve dysfunction. That
there is no apparent difference in those with versus
those without significant valve dysfunction is therefore
remarkable.
Conclusions
The nonagenarian population has a high prevalence of
significant valvular heart disease, in the presence of pre-
served systolic LV function, without LV dilatation. The
presence of significant valve disease did not impact
negatively on the ability to perform activities of daily liv-
ing. Therefore, in this age group one should be cautious
before undertaking any medical intervention because of
valvulopathy.
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